Africa Links 24 with Puyeipawa Nakashole
Published on 2025-05-22 17:00:00
Namibia currently lacks the capacity to manufacture malaria treatment medication due to high costs and stringent international regulatory requirements.
This was confirmed by Fabupharm managing director Fanie Badenhorst, who said the pharmaceutical manufacturer discontinued its malaria drug production several years ago due to ineffectiveness and financial limitations.
“The chloroquine product that we used to manufacture is an old molecule which malaria parasites have become resistant…
Read the Full article on The Namibian
